Non-Hodgkin LymphomaCAST
PTCL - Diagnosis & Treatment Update - Part 1
Date: Wednesday, May 29, 2013
Speaker: Julie M. Vose, MD, MBA
Topics Covered:
PTCL and PTCL subtypes
Treatment options for patients with newly diagnosed, refractory or relapsed PTCL
The role of clinical trials as treatment options for patients with PTCL
Patient-provider communications about treatment options, including clinical trials
Patient-provider communications about side effects management